Preclinical efficacy of LP-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma. Lal B, Kulkarni A, McDermott J, Rais R, et al. Clin Cancer Res 2023 Jul 26:CCR-23-0673. doi: 10.1158/1078-0432.CCR-23-0673.

Read + Share

Amedeo Smart

Independent Medical Education

Lal B, Kulkarni A, McDermott J, Rais R, et al. Preclinical efficacy of LP-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma. Clin Cancer Res 2023 Jul 26:CCR-23-0673. doi: 10.1158/1078-0432.CCR-23-0673.
PMID: 37494541